DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Antibiotic

Antibiotic

  • National Antibiotic Consumption for Human Use in Sierra Leone (2017–2019): a Cross-Sectional Study

    National Antibiotic Consumption for Human Use in Sierra Leone (2017–2019): a Cross-Sectional Study

  • Novel Antimicrobial Agents Inhibiting Lipid II Incorporation Into Peptidoglycan Essay MBB

    Novel Antimicrobial Agents Inhibiting Lipid II Incorporation Into Peptidoglycan Essay MBB

  • Brilacidin First-In-Class Defensin-Mimetic Drug Candidate

    Brilacidin First-In-Class Defensin-Mimetic Drug Candidate

  • Penicillin Allergy Guidance Document

    Penicillin Allergy Guidance Document

  • Antibiotic Resistance: Nosopharm and the University of Illinois at Chicago Describe Mechanism of Action of New Class of Antibiotics in Molecular Cell

    Antibiotic Resistance: Nosopharm and the University of Illinois at Chicago Describe Mechanism of Action of New Class of Antibiotics in Molecular Cell

  • Polymyxin B* Class: Polymyxins Overview Polymyxin B Is a Polypeptide Bactericidal Antibiotic. the Polymyxins Were Discovered In

    Polymyxin B* Class: Polymyxins Overview Polymyxin B Is a Polypeptide Bactericidal Antibiotic. the Polymyxins Were Discovered In

  • Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept

    Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept

  • Third ESVAC Report

    Third ESVAC Report

  • Non-Penicillin Beta-Lactam Drugs: a CGMP Framework for Preventing Cross- Contamination

    Non-Penicillin Beta-Lactam Drugs: a CGMP Framework for Preventing Cross- Contamination

  • A Practical Guide to the Use of the Anatomical Therapeutic Chemical Classification and Defined Daily Dose System Methodology in Canada

    A Practical Guide to the Use of the Anatomical Therapeutic Chemical Classification and Defined Daily Dose System Methodology in Canada

  • Antibiotic Resistance Threats in the United States, 2019

    Antibiotic Resistance Threats in the United States, 2019

  • Public Health Reviews

    Public Health Reviews

  • Guidelines for Atcvet Classification 2012

    Guidelines for Atcvet Classification 2012

  • Brilacidin Demonstrates Inhibition of SARS-Cov-2 in Cell Culture

    Brilacidin Demonstrates Inhibition of SARS-Cov-2 in Cell Culture

  • Interventions for Tuberculosis Control and Elimination

    Interventions for Tuberculosis Control and Elimination

  • The Antibiotic Crisis: Time to Wake Up!

    The Antibiotic Crisis: Time to Wake Up!

  • European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Sales Data and Animal Population Data Reporting Protocol (Version 4)

    European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Sales Data and Animal Population Data Reporting Protocol (Version 4)

  • In Vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of NOSO-502, a First-In-Class Odilorhabdin Antibiotic, Against E

    In Vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of NOSO-502, a First-In-Class Odilorhabdin Antibiotic, Against E

Top View
  • Synergy and Duality in Peptide Antibiotic Mechanisms Dewey G Mccafferty*, Predrag Cudic, Michael K Yu, Douglas C Behenna and Ryan Kruger
  • DRIVE-AB REPORT Revitalizing the Antibiotic Pipeline
  • Antibiotic Use and Antibiotic Resistance: Answers for Patients
  • Performance of the Belgian Health System – Report 2019 – Supplement
  • Annual Report of Antibiotic and Antimycotic Consumption 2019
  • Beta-Lactam Allergy Tip Sheet
  • Cyclic Antibiotic Peptides
  • Antibiotic-Overview.Pdf
  • Antibiotics & Common Infections
  • The Decrease in Antibiotic Funding
  • Antibiotics Made Easy
  • Nosopharm and Evotec Enter Into Collaboration to Accelerate Development of Novel Antibiotics
  • Antibiotics: Frequently Asked Questions
  • A4 - a NOVEL PEPTIDE ANTIBIOTIC ID: 4006 Featured Innovators: Y
  • Penicillin…He Will Come Home!” the Challenge of Mass Production
  • AAE Guidance on the Use of Systemic Antibiotics in Endodontics
  • Group 5 Drugs for Multidrug-Resistant Tuberculosis: Individual Patient Data Meta-Analysis
  • Antibiotics Aren't Always the Answer


© 2024 Docslib.org    Feedback